Oxytocin research stands at the intersection of neurobiology, endocrinology, and behavioral science. Traditionally recognized for its roles in childbirth ...
Neuropathic pain is nerve pain coming from malfunctions of or damage to the nervous system (brain, spinal cord, peripheral nerves). It is different from pain messages that are carried along healthy ...
A long-awaited change in drug policy could bring scientists one step closer to understanding the harms and benefits of marijuana, the most commonly used federally illegal substance. On Thursday, ...
With the federal designation for marijuana about to change, we asked you to send us your burning questions about the marijuana reclassification — here are the answers. President Trump signed an ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
President Donald Trump's order reclassifying marijuana was the first major change to the drug on a federal level in more than 50 years. For states like New Jersey, where use of the drug was already ...
President Trump signed an executive order to reclassify marijuana as a less dangerous drug. The order moves marijuana from a Schedule I to a Schedule III substance at the federal level. This ...
Forbes contributors publish independent expert analyses and insights. Nathan Goldman is a tax prof. at NC State Univ. On December 18, President Trump issued an executive order titled “Increasing ...
While recreational cannabis use has been legal in Canada since 2018, it’s important to know that daily or near daily cannabis consumption can have negative effects on your mental health and brain ...
President Trump has ordered the federal reclassification of marijuana from a Schedule I to a Schedule III substance. The reclassification would not make marijuana federally legal but would ease ...
A Rosalind Franklin University neuroscientist is collaborating with the Icahn School of Medicine in New York to delve into how social recognition memory works, and doesn't work, in patients with ...